ICCM IceCure Medical Ltd.

Fundamentals / CIK 0001584371 / USD

IceCure Medical Ltd. reported $3.38M in revenue and a net loss of $15.06M for the fiscal year ended December 31, 2025 (up 2.7% year over year), with a 36.3% gross margin and a -446.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ICCM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$5.87M$2.94M$0-$16.23MFY 2020 Revenue: $3.87MFY 2020 Net Income: -$3.73M2020FY 2021 Revenue: $4.14MFY 2021 Net Income: -$9.89M2021FY 2022 Revenue: $3.08MFY 2022 Net Income: -$16.98M2022FY 2023 Revenue: $3.23MFY 2023 Net Income: -$14.65M2023FY 2024 Revenue: $3.29MFY 2024 Net Income: -$15.32M2024FY 2025 Revenue: $3.38MFY 2025 Net Income: -$15.06M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $3.38M $3.29M $3.23M $3.08M $4.14M $3.87M
Cost of Revenue $2.15M $1.84M $1.93M $1.64M $1.94M $1.42M
Gross Profit $1.23M $1.45M $1.30M $1.45M $2.19M $2.44M
Research & Development $7.43M $7.10M $8.27M $9.12M $5.88M $3.81M
Selling, General & Admin $8.89M $10.05M $8.60M $735K $177K $120K
Operating Income -$15.09M -$15.70M -$15.58M -$16.74M -$9.72M -$4.14M
EBITDA -$14.80M -$15.36M -$15.25M -$16.49M -$9.60M -$4.08M
Net Income -$15.06M -$15.32M -$14.65M -$16.98M -$9.89M -$3.73M
Basic EPS $0.24 $0.30 $0.32 $0.46 $0.35 $0.22
Diluted EPS $0.24 $0.30 $0.32 $0.46 $0.35 $0.22
Basic Shares Outstanding 63.6M 50.9M 45.6M 37.0M 28.5M 17.1M
Diluted Shares Outstanding 63.6M 50.9M 45.6M 37.0M 28.5M 17.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for ICCM.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.90M $7.56M $10.53M $23.66M $25.62M $3.50M
Short-Term Investments -- -- $529K -- -- --
Cash & Short-Term Investments $8.90M $7.56M $11.06M $23.66M $25.62M $3.50M
Accounts Receivable, Net $331K $221K $103K $78K $456K $94K
Inventory $2.62M $1.99M $2.27M $2.86M $1.96M $1.06M
Total Current Assets $12.61M $10.75M $14.18M $28.13M $30.32M $9.59M
Property, Plant & Equipment, Net $993K $1.25M $1.51M $1.36M $713K $307K
Total Non-Current Assets $1.28M $1.82M $2.23M $2.06M $1.96M $650K
Total Assets $13.89M $12.58M $16.41M $30.19M $32.28M $10.24M
Accounts Payable $863K $1.23M $502K $714K $881K $645K
Deferred Revenue (Current) $255K $334K $187K $646K $884K $1.38M
Other Current Liabilities $1.10M $1.23M $3.15M $3.46M $2.92M $2.85M
Total Current Liabilities $4.82M $5.51M $3.87M $4.34M $4.02M $3.71M
Long-Term Debt $13K $161K -- -- -- --
Total Non-Current Liabilities $13K $161K $376K $430K $1.30M $877K
Total Liabilities $4.84M $5.67M $4.25M $4.77M $5.32M $4.59M
Total Debt (incl. Leases) $230K $620K $599K $597K $909K $332K
Retained Earnings -$120.4M -$105.4M -$90.06M -$75.41M -$58.43M -$48.54M
Total Stockholders' Equity $9.05M $6.90M $12.16M $25.42M $26.96M $5.65M
Total Equity $9.05M $6.90M $12.16M $25.42M $26.96M $5.65M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Cash & Cash Equivalents $8.90M $7.56M $10.53M $23.66M $25.62M $3.50M
Short-Term Investments -- -- $529K -- -- --
Cash & Short-Term Investments $8.90M $7.56M $11.06M $23.66M $25.62M $3.50M
Accounts Receivable, Net $331K $221K $103K $78K $456K $94K
Inventory $2.62M $1.99M $2.27M $2.86M $1.96M $1.06M
Total Current Assets $12.61M $10.75M $14.18M $28.13M $30.32M $9.59M
Property, Plant & Equipment, Net $993K $1.25M $1.51M $1.36M $713K $307K
Total Non-Current Assets $1.28M $1.82M $2.23M $2.06M $1.96M $650K
Total Assets $13.89M $12.58M $16.41M $30.19M $32.28M $10.24M
Accounts Payable $863K $1.23M $502K $714K $881K $645K
Deferred Revenue (Current) $255K $334K $187K $646K $884K $1.38M
Other Current Liabilities $1.10M $1.23M $3.15M $3.46M $2.92M $2.85M
Total Current Liabilities $4.82M $5.51M $3.87M $4.34M $4.02M $3.71M
Long-Term Debt $13K $161K -- -- -- --
Total Non-Current Liabilities $13K $161K $376K $430K $1.30M $877K
Total Liabilities $4.84M $5.67M $4.25M $4.77M $5.32M $4.59M
Total Debt (incl. Leases) $230K $620K $599K $597K $909K $332K
Retained Earnings -$120.4M -$105.4M -$90.06M -$75.41M -$58.43M -$48.54M
Total Stockholders' Equity $9.05M $6.90M $12.16M $25.42M $26.96M $5.65M
Total Equity $9.05M $6.90M $12.16M $25.42M $26.96M $5.65M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$15.06M -$15.32M -$14.65M -$16.98M -$9.89M -$3.73M
Depreciation & Amortization $295K $332K $323K $248K $127K $63K
Stock-Based Compensation $1.37M $869K $1.31M $1.86M $316K $229K
Change in Receivables -$110K -$118K -$25K $378K -$362K -$77K
Change in Inventory -$637K $287K $582K -$902K -$891K --
Change in Payables -$369K $730K -$212K -$167K $236K $217K
Operating Cash Flow -$14.57M -$12.56M -$12.55M -$14.29M -$12.61M -$3.69M
Capital Expenditure -$36K -$71K -$480K -$891K -$533K -$223K
Free Cash Flow -$14.61M -$12.63M -$13.03M -$15.18M -$13.14M -$3.91M
Purchases of Investments -$5.00M -$1.37M -$500K -- -- --
Investing Cash Flow -$36K $446K -$684K -$891K $3.79M -$4.67M
Common Stock Issued -- $9.19M -- $13.57M $14.59M $5.85M
Financing Cash Flow $15.83M $9.19M $83K $13.58M $30.89M $5.86M
Net Change in Cash $1.22M -$2.93M -$13.15M -$1.61M $22.08M -$2.50M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for ICCM.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 36.3% 44.1% 40.3% 46.8% 53.0% 63.2%
Operating Margin -446.7% -476.9% -482.4% -542.6% -235.0% -107.1%
Net Profit Margin -445.6% -465.5% -453.8% -550.3% -239.1% -96.4%
Return on Equity (ROE) -166.4% -222.0% -120.5% -66.8% -36.7% -66.0%
Return on Assets (ROA) -108.4% -121.8% -89.3% -56.2% -30.7% -36.4%
Current Ratio 2.61x 1.95x 3.66x 6.49x 7.54x 2.58x
Quick Ratio 2.07x 1.59x 3.08x 5.83x 7.06x 2.30x
Debt to Equity 0.03x 0.09x 0.05x 0.02x 0.03x 0.06x
Revenue Growth (YoY) +2.7% +1.9% +4.7% -25.4% +7.0% --
Gross Profit Growth (YoY) -15.5% +11.6% -10.0% -34.2% -10.2% --
EPS Growth (YoY) -20.0% -6.3% -30.4% +31.4% +59.1% --
5Y Revenue / Share Growth -76.5% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for ICCM.
Source: SEC EDGAR CompanyFacts (CIK 0001584371) · from December 31, 2020 Data through December 31, 2025 · synced Nov 21, 2026, 05:12 UTC · Open in terminal